The FDA Has Cleared Centessa Pharmaceuticals' Investigational New Drug Application To Initiate A Phase 1 First-in-human, Clinical Trial Of ORX750 For Narcolepsy
The FDA Has Cleared Centessa Pharmaceuticals' Investigational New Drug Application To Initiate A Phase 1 First-in-human, Clinical Trial Of ORX750 For Narcolepsy
美國食品藥品管理局已批准 Centessa Pharmaceuticals 的研究性新藥申請，以啓動 ORX750 治療發作性睡病的 1 期首次人體臨床試驗
The FDA Has Cleared Centessa Pharmaceuticals' Investigational New Drug Application To Initiate A Phase 1 First-in-human, Clinical Trial Of ORX750 For Narcolepsy
美國食品藥品管理局已批准 Centessa Pharmaceuticals 的研究性新藥申請，以啓動 ORX750 治療發作性睡病的 1 期首次人體臨床試驗
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。